Nifurtimox

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Antiprotozoan agent, nitrofuran derivative.

Half-lifeThis section has been translated automatically.

3 h

IndicationThis section has been translated automatically.

Sleeping sickness.

Dosage and method of useThis section has been translated automatically.

  • Adults: 2-2,5 mg/kg bw/6 hours for 3-4 months.
  • Children: 4-6 mg/kg bw/6 hrs

Remember! The therapy should only be done under medical supervision!

Undesirable effectsThis section has been translated automatically.

Fatigue, allergic reactions, gastrointestinal disorders, convulsions, headaches, paresthesias, polyneuritis, sleep disorders, dizziness, tremor.

InteractionsThis section has been translated automatically.

Alcohol consumption can increase toxicity.

ContraindicationThis section has been translated automatically.

Neurological or psychiatric diseases, alcoholism.

PreparationsThis section has been translated automatically.

Lampit

Note(s)This section has been translated automatically.

Not approved as a preparation in Germany (off-label use!)

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer